Urology
Volume 67, Issue 6 , Pages 1235-1240 , June 2006

Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes

Presented in part at the 2005 Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida.

Received 11 October 2005 ,Accepted 4 January 2006.

References 

  1. Jemal A , Murray T , Ward E , et al.   Cancer statistics 2005 . CA Cancer J Clin . 2005;55:10–30
  2. Debes JD , Tindall DJ . Mechanisms of androgen-refractory prostate cancer . N Engl J Med . 2004;351:1488–1490
  3. Crawford E , Eisenberger M , McLeod D , et al.   A controlled trial of leuprolide with and without flutamide in prostatic carcinoma . N Engl J Med . 1989;321:419–424
  4. Gilligan T , Kantoff PW . Chemotherapy for prostate cancer . Urology . 2002;60:94–100
  5. Kantoff PW , Halabi S , Conaway M , et al.   Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer (results of the Cancer and Leukemia Group B 9182 study) . J Clin Oncol . 1999;17:2506–2513
  6. Tannock IF , Osaba D , Stockler M , et al.   Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer (a Canadian randomized trial with palliative end points) . J Clin Oncol . 1996;14:1756–1764
  7. Tannock IF , Wit RD , Berry WR , et al.   Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer . N Engl J Med . 2004;351:1502–1512
  8. Petrylak DP , Tangen CM , Hussain M , et al.   Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer . N Engl J Med . 2004;351:1513–1520
  9. Rosenberg J , Small EJ . Secondary chemotherapy (has the time come?) . Clin Prostate Cancer . 2004;3:122–124
  10. Rosenberg J , Kelly WK , Michaelson MD , et al.   A randomized phase II study of ixabepilone or mitoxantrone and prednisone (MP) in patients with taxane-refractory hormone refractory prostate cancer (HRPC) . (abstract) Proc Am Soc Clin Oncol . 2005;23:4566
  11. Bubley GJ , Carducci M , Dahut W , et al.   Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer (recommendations from the Prostate-Specific Antigen Working Group) . J Clin Oncol . 1999;17:3461–3467
  12. Cox DR . Analysis of Binary Data. . London: Methuen; 1970;
  13. Mehta CR , Patel NR , Tsiatis AA . Exact significance testing for ordered categorical data . Biometrics . 1984;40:819–825
  14. Kaplan EL , Meier P . Nonparametric estimation from incomplete observations . J Am Stat Assoc . 1958;53:457–481
  15. Peto R , Peto J . Asymptotically efficient rank invariant test procedures . J Royal Stat Soc A . 1972;135:185–206
  16. Cox DR . Regression models and life tables . J Royal Stat Soc B . 1972;34:181–220
  17. Joshua AM , Nordman I , Venkataswaran R , et al.   Weekly docetaxel as second line treatment after mitoxantrone for androgen-independent prostate cancer . Intern Med J . 2005;35:468–472
  18. Beekman KW , Fleming MT , Scher HI , et al.   Second-line chemotherapy for prostate cancer (patient characteristics and survival) . Clin Prostate Cancer . 2005;4:86–89
  19. Urakami S , Yoshino T , Kikuno N , et al.   Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer (a pilot study) . Urology . 2005;65:543–548
  20. Oh WK , George DJ , Tay MH . Response to docetaxel plus carboplatin in patients who have progressed on taxane chemotherapy . Clin Prostate Cancer . 2005;4:61–64
  21. Sternberg CN , Whelan P , Hetherington J , et al.   Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer . Oncology . 2005;68:2–9

 This work was supported by the Richard Almy Fund for Prostate Cancer, the C. Brendan Noonan, Jr Charitable Foundation, and the Arthur and Linda Gelb Center for Translational Medicine.

PII: S0090-4295(06)00068-9

doi: 10.1016/j.urology.2006.01.006

Urology
Volume 67, Issue 6 , Pages 1235-1240 , June 2006

Article Tools

* Image Usage & Resolution